A Cellular Automata Model of Oncolytic Virotherapy in Pancreatic Cancer

Journal Article (2020)
Author(s)

J. Chen (TU Delft - Numerical Analysis, Amsterdam UMC)

D. Weihs (Technion Israel Institute of Technology)

F. J. Vermolen (TU Delft - Numerical Analysis, University of Hasselt)

Research Group
Numerical Analysis
Copyright
© 2020 J. Chen, D. Weihs, F.J. Vermolen
DOI related publication
https://doi.org/10.1007/s11538-020-00780-5
More Info
expand_more
Publication Year
2020
Language
English
Copyright
© 2020 J. Chen, D. Weihs, F.J. Vermolen
Research Group
Numerical Analysis
Issue number
8
Volume number
82
Pages (from-to)
1-25
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Oncolytic virotherapy is known as a new treatment to employ less virulent viruses to specifically target and damage cancer cells. This work presents a cellular automata model of oncolytic virotherapy with an application to pancreatic cancer. The fundamental biomedical processes (like cell proliferation, mutation, apoptosis) are modeled by the use of probabilistic principles. The migration of injected viruses (as therapy) is modeled by diffusion through the tissue. The resulting diffusion–reaction equation with smoothed point viral sources is discretized by the finite difference method and integrated by the IMEX approach. Furthermore, Monte Carlo simulations are done to quantitatively evaluate the correlations between various input parameters and numerical results. As we expected, our model is able to simulate the pancreatic cancer growth at early stages, which is calibrated with experimental results. In addition, the model can be used to predict and evaluate the therapeutic effect of oncolytic virotherapy.